litlas
ログインアカウント作成

Frédéric Houssiau

1978–2025 年に発表

別表記
Fréderic Houssiau
87
論文数
24,217
被引用数
63
h 指数
87
i10 指数

被引用数

Frédéric Houssiau の年別被引用数1978 年: 被引用 3 件1983 年: 被引用 2 件1988 年: 被引用 6 件1989 年: 被引用 30 件1990 年: 被引用 56 件1991 年: 被引用 49 件1992 年: 被引用 45 件1993 年: 被引用 42 件1994 年: 被引用 44 件1995 年: 被引用 32 件1996 年: 被引用 41 件1997 年: 被引用 39 件1998 年: 被引用 55 件1999 年: 被引用 47 件2000 年: 被引用 59 件2001 年: 被引用 39 件2002 年: 被引用 58 件2003 年: 被引用 68 件2004 年: 被引用 78 件2005 年: 被引用 98 件2006 年: 被引用 79 件2007 年: 被引用 57 件2008 年: 被引用 65 件2009 年: 被引用 95 件2010 年: 被引用 82 件2011 年: 被引用 97 件2012 年: 被引用 122 件2013 年: 被引用 102 件2014 年: 被引用 121 件2015 年: 被引用 170 件2016 年: 被引用 179 件2017 年: 被引用 138 件2018 年: 被引用 119 件2019 年: 被引用 525 件2020 年: 被引用 682 件2021 年: 被引用 703 件2022 年: 被引用 687 件2023 年: 被引用 541 件2024 年: 被引用 877 件2025 年: 被引用 423 件2026 年: 被引用 9 件1979〜1982 年は被引用が無いため表示していません1984〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,594 件、この内訳の 18.9%イギリス: 引用元論文 615 件、この内訳の 7.3%イタリア: 引用元論文 576 件、この内訳の 6.8%中国: 引用元論文 540 件、この内訳の 6.4%フランス: 引用元論文 420 件、この内訳の 5%ドイツ: 引用元論文 379 件、この内訳の 4.5%スペイン: 引用元論文 349 件、この内訳の 4.2%カナダ: 引用元論文 317 件、この内訳の 3.8%日本: 引用元論文 311 件、この内訳の 3.7%オランダ: 引用元論文 267 件、この内訳の 3.2%スウェーデン: 引用元論文 221 件、この内訳の 2.6%オーストラリア: 引用元論文 214 件、この内訳の 2.5%
0%18.9%その他 31.1%

機関

分野

  • Medicine83.5%
  • Immunology and Microbiology9%
  • Biochemistry, Genetics and Molecular Biology5%
  • Neuroscience1%
  • Dentistry0.3%
  • Computer Science0.2%
  • その他1%

トピック

  • Systemic Lupus Erythematosus Research19.2%
  • Rheumatoid Arthritis Research and Therapies5.8%
  • T-cell and B-cell Immunology4.4%
  • Monoclonal and Polyclonal Antibodies Research3.5%
  • Systemic Sclerosis and Related Diseases3.4%
  • Renal Diseases and Glomerulopathies3%
  • その他60.7%

共著者

全論文

検索で開く
  1. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    著者: Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang‐Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard Furie, Dafna D. Gladman, Frédéric Houssiau, Luís Inês, David Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F. Morand, Gabriella Moroni, Marta Mosca, Johanna Mücke, Chetan Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José María Pego‐Reigosa, Michelle Petri, Bernardo A. Pons‐Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2023 被引用: 933

  2. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    著者: Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg M. Bajema, John Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni, Frédéric Houssiau, David Jayne, Marios Kouloumas, Annegret Kuhn, J.L. Larsen, Kirsten Lerstrøm, Gabriella Moroni, Marta Mosca, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Vladimı́r Tesař, Anǵela Tincani, Anne Troldborg, Ronald van Vollenhoven, Joerg Wenzel, George Βertsias, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2019 被引用: 2,017

  3. Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

    著者: Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B. Santiago, Amit Saxena, Yulia Green, Beulah Ji, C. Kleoudis, Susan W. Burriss, Carly Barnett, David A. Roth - New England Journal of Medicine 2020 被引用: 973

  4. 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

    著者: Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans‐Joachim Anders, Martin Aringer, Ingeborg M. Bajema, John Boletis, Eleni Frangou, Frédéric Houssiau, Jane Hollis, A. Karras, Francesca Marchiori, Stephen D. Marks, Gabriella Moroni, Marta Mosca, Ioannis Parodis, Manuel Praga, Matthias Schneider, Josef S Smolen, Vladimı́r Tesař, Maria Trachana, Ronald van Vollenhoven, Alexandre E. Voskuyl, Y K Onno Teng, Bernadette van Leew, George Βertsias, David Jayne, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2020 被引用: 807

  5. 2021 DORIS definition of remission in SLE: final recommendations from an international task force

    著者: Ronald van Vollenhoven, George Βertsias, Andrea Doria, David Isenberg, Eric F. Morand, Michelle Petri, Bernardo A. Pons‐Estel, Anisur Rahman, Manuel F. Ugarte‐Gil, Alexandre E. Voskuyl, Laurent Arnaud, Ian N Bruce, Ricard Cervera, N. Costedoat‐Chalumeau, Caroline Gordon, Frédéric Houssiau, Marta Mosca, Matthias Schneider, Michael M. Ward, Graciela S. Alarcón, Martin Aringer, Anca Askanase, Sang‐Cheol Bae, Hendrika Bootsma, Dimitrios T. Boumpas, Hermine I. Brunner, Ann E. Clarke, Cindy Coney, László Czirják, Thomas Dörner, Raquel Faria, Rebecca S. B. Fischer, Ruth Fritsch‐Stork, Murat İnanç, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Olesińska, Guillermo Pons‐Estel, Juanita Romero‐Díaz, Blanca Rubio, Y Schoenfeld, Eloísa Bonfá, Josef S Smolen, Y K Onno Teng, Anǵela Tincani, Michel Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharhova, Cynthia Aranow - Lupus Science & Medicine 2021 被引用: 349

  6. Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis

    著者: David Jayne, Brad H. Rovin, Eduardo Mysler, Richard Furie, Frédéric Houssiau, Teodora Trasieva, J. Knagenhjelm, Erik Schwetje, Yen Lin Chia, Raj Tummala, Catharina Lindholm - Annals of the Rheumatic Diseases 2022 被引用: 194

  7. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    著者: Ronald van Vollenhoven, Marta Mosca, George Βertsias, David Isenberg, Annegret Kuhn, Kirsten Lerstrøm, Martin Aringer, Hendrika Bootsma, Dimitrios Boumpas, Ian N Bruce, Ricard Cervera, Ann E. Clarke, N. Costedoat‐Chalumeau, László Czirják, Ronald H. W. M. Derksen, Thomas Dörner, Caroline Gordon, W. Graninger, Frédéric Houssiau, Murat İnanç, Søren Jacobsen, David Jayne, Anna Jędryka-Góral, Adrian Levitsky, Roger A. Levy, Xavier Mariette, Eric F. Morand, Sandra Navarra, Irmgard Neumann, Anisur Rahman, Jozef Rovenský, Josef S Smolen, Carlos Vasconcelos, Alexandre E. Voskuyl, Anne Voss, Elena Zakharova, Asad Zoma, Matthias Schneider - Annals of the Rheumatic Diseases 2014 被引用: 727

  8. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

    著者: Ricard Cervera, Jean‐Charles Piette, Josep Font, Munther A. Khamashta, Yehuda Shoenfeld, María Teresa Camps, Søren Jacobsen, Gabriella Lakos, Anǵela Tincani, I. Kontopoulou‐Griva, Mauro Galeazzi, Pier Luigi Meroni, Ronald H. W. M. Derksen, Philip G. de Groot, Erika Gromnica‐Ihle, Marta Baleva, Marta Mosca, Stefano Bombardieri, Frédéric Houssiau, Jean‐Christophe Gris, I. Quéré, É. Hachulla, Carlos Vasconcelos, Beate Roch, Antonio Fernández‐Nebro, Marie‐Claire Boffa, Graham R.V. Hughes, M Ingelmo - Arthritis & Rheumatism 2002 被引用: 2,154

  9. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    著者: Ronald van Vollenhoven, Alexandre E. Voskuyl, George Βertsias, Cynthia Aranow, Martin Aringer, Laurent Arnaud, Anca Askanase, Petra Balážová, Eloísa Bonfá, Hendrika Bootsma, Dimitrios T. Boumpas, Ian N Bruce, Ricard Cervera, Ann E. Clarke, Cindy Coney, N. Costedoat‐Chalumeau, László Czirják, Ronald H. W. M. Derksen, Andrea Doria, Thomas Dörner, Rebecca Fischer‐Betz, Ruth Fritsch‐Stork, Caroline Gordon, W. Graninger, N. Györi, Frédéric Houssiau, David Isenberg, Søren Jacobsen, David Jayne, Annegret Kuhn, Véronique Le Guern, Kirsten Lerstrøm, Roger A. Levy, Francinne Machado-Ribeiro, Xavier Mariette, Jamil Missaykeh, Eric F. Morand, Marta Mosca, Murat İnanç, Sandra Navarra, Irmgard Neumann, Marzena Olesińska, Michelle Petri, Anisur Rahman, Ole Petter Rekvig, Jozef Rovenský, Yehuda Shoenfeld, Josef S Smolen, Anǵela Tincani, Murray B. Urowitz, Bernadette van Leeuw, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharova, Asad Zoma, Matthias Schneider, Michael M. Ward - Annals of the Rheumatic Diseases 2016 被引用: 357

  10. Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period

    著者: Ricard Cervera, Munther A. Khamashta, Josep Font, Gian Domenico Sebastiani, Antonio Gil, Paz Lavilla, Juan Carlos Mejía, AO. Aydintug, H Chwalińska-Sadowska, Enrique de Ramón, Antonio Fernández‐Nebro, Mauro Galeazzi, Merete Valen, Alessandro Mathieu, Frédéric Houssiau, N Caro, Paula Alba, Manuel Ramos‐Casals, M Ingelmo, Graham Hughes - Medicine 2003 被引用: 1,385

  11. Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

    著者: Frédéric Houssiau, Carlos Vasconcelos, David D’Cruz, Gian Domenico Sebastiani, Enrique de Ramón Garrido, Maria Giovanna Danieli, Daniel Abramovicz, Daniël Blockmans, Alessandro Mathieu, Haner Di̇reskeneli̇, Mauro Galeazzi, Ahmet Gül, Yair Levy, P Petera, Rajko Popović, Radmila Petrović, Renato Alberto Sinico, Roberto Cattaneo, Josep Font, Geneviève Depresseux, Jean‐Pierre Cosyns, Ricard Cervera - Arthritis & Rheumatism 2002 被引用: 1,071

  12. Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study

    著者: Eduardo Mysler, Alberto Spindler, Renato Guzmán, Marc Bijl, David Jayne, Richard Furie, Frédéric Houssiau, Jörn Drappa, D. Close, Romeo Maciuca, Kajal Rao, Saba Shahdad, Paul Brunetta - Arthritis & Rheumatism 2013 被引用: 354

  13. Predictors of Long‐Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro‐Lupus Nephritis Cohort

    著者: Maria Dall’Era, Miriam G. Cisternas, Dawn E. Smilek, Laura Straub, Frédéric Houssiau, Ricard Cervera, Brad H. Rovin, Meggan Mackay - Arthritis & Rheumatology 2015 被引用: 318

  14. A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial

    著者: Farah Tamirou, Bernard Lauwerys, Maria Dall’Era, Meggan Mackay, Brad H. Rovin, Ricard Cervera, Frédéric Houssiau - Lupus Science & Medicine 2015 被引用: 235

  15. Prediction of prognosis and renal outcome in lupus nephritis

    著者: Ioannis Parodis, Farah Tamirou, Frédéric Houssiau - Lupus Science & Medicine 2020 被引用: 129

  16. Safety and Efficacy of Belimumab in Patients with Lupus Nephritis

    著者: Richard Furie, Brad H. Rovin, Frédéric Houssiau, Gabriel Contreras, Y K Onno Teng, Paula Curtis, Yulia Green, Mohamed Okily, Anuradha Madan, David A. Roth - Clinical Journal of the American Society of Nephrology 2022 被引用: 74

  17. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

    著者: Nancy Agmon‐Levin, Jan Damoiseaux, Cees G. M. Kallenberg, Ulrich Sack, Torsten Witte, Manfred Herold, Xavier Bossuyt, L. Musset, Ricard Cervera, Aresio Plaza-Lopez, Carlos Dias, Maria José Rego de Sousa, Antonella Radice, Catharina Eriksson, Olof Hultgren, M. Viander, Munther A. Khamashta, Stephan Regenass, Luís Eduardo Coelho Andrade, Allan Wiik, Anǵela Tincani, Johan Rönnelid, Donald B. Bloch, Marvin J. Fritzler, Edward K. L. Chan, Ignacio Garcı́a-De La Torre, Konstantin N. Konstantinov, Robert G. Lahita, Merlin R. Wilson, Olli Vainio, Nicole Fabien, Renato Alberto Sinico, Pier Luigi Meroni, Yehuda Shoenfeld, JW Cohen Tervaert, D Hamann, RHWM Derksen, H Hooijkaas, I Klasen, P Limburg, R Smeenk, P van Daele, Kerstin Elvin, Charlotte Dahle, Thomas Skogh, Jaakko Antonen, Anna-Maija Haapala, Marja Hietarinta, Teija Häkkinen, Arno Hänninen, Sakari Jokiranta, Anna Karjalainen, Aino Laatikainen, Marjatta Leirisalo-Repo, Riitta Luosujärvi, Aaro Miettinen, Jari Siuro, Sune Sved, Tamara Tuuminen, Timo Walle, Fátima Coelho, Maria José Santos, Mónica Bogas, João P Ramos, João Faro-Viana, Nils Olivier Olsson, Georges Chyderiotis, Bach-Nga, Vincent Aubert, Clemens Dahinden, Eric Dayer, Françoise Mascart, Jean-Paul Tomasi, Martine Vercammen, Patrick Verschueren, Fréderic Houssiau, Bernard Lauwerys, Filip De Keyser, Walter Fierz, Ingmar Heijnen, Franco Keller, Gerhard Müllner, Stephan Regenass, Pascale Roux-Lombard, Urs Wirthmüller, Boris Gilburde, Rachel Levi, Daphna Lipinsky, Mira Barak, Abu-Shakra Mahmud, Ruth Fishel, Mina Foguel, Kivity Shay, Elena Csernok, Bernhard Schlüter, Bettina Becker, Rudolf Mierau, Torsten Witte, Wolfram Seidel, Ingrid Frank ほか 25 名 - Annals of the Rheumatic Diseases 2013 被引用: 612

  18. Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study

    著者: Richard Furie, Kathy Nicholls, Tien‐Tsai Cheng, Frédéric Houssiau, Rubén Burgos‐Vargas, Shun‐le Chen, Jan Hillson, S. Meadows–Shropshire, M. Kinaszczuk, Joan T. Merrill - Arthritis & Rheumatology 2013 被引用: 334

  19. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    著者: George Βertsias, Maria G. Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg M. Bajema, Jo H. M. Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria, Franco Ferrario, Jürgen Floege, Frédéric Houssiau, John P. A. Ioannidis, David Isenberg, Cees G. M. Kallenberg, Liz Lightstone, Stephen D. Marks, Alberto Martini, Gabriela Moroni, Irmgard Neumann, Manuel Praga, Matthias Schneider, Argyre Starra, Vladimı́r Tesař, Carlos Vasconcelos, Ronald van Vollenhoven, Elena Zakharova, Marion Haubitz, Caroline Gordon, David Jayne, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2012 被引用: 1,026

  20. Systemic Lupus Erythematosus

    著者: Ricard Cervera, Munther A. Khamashta, Josep Font, Gian Domenico Sebastiani, ANTONIO GIL, Paz Lavilla, Ines Domenech, AO. Aydintug, Anna Jędryka-Góral, Enrique de Ramón, Mauro Galeazzi, Hans‐Jacob Haga, Alessandro Mathieu, Frédéric Houssiau, M Ingelmo, Graham R.V. Hughes - Medicine 1993 被引用: 982

  21. From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies

    著者: Marc Xipell, Gema M. Lledó, Allyson Egan, Farah Tamirou, Cristina Serrano del Castillo, Jordi Rovira, José A. Gómez‐Puerta, Adriana García‐Herrera, Ricard Cervera, Andreas Kronbichler, David Jayne, Hans‐Joachim Anders, Frédéric Houssiau, Gerard Espinosa, Luís F. Quintana - Autoimmunity Reviews 2023 被引用: 48

  22. IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study

    著者: Frédéric Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skóra, Risto Perich-Campos, С. А. Смакотина, Sergio Cerpa Cruz, B. Louzir, Thérèse Croughs, Michael Tee - Annals of the Rheumatic Diseases 2019 被引用: 110

  23. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

    著者: Frédéric Houssiau, Carlos Vasconcelos, D. D’Cruz, Gian Domenico Sebastiani, Enrique de Ramón Garrido, Maria Giovanna Danieli, Daniel Abramovicz, Daniël Blockmans, Alberto Cauli, Haner Di̇reskeneli̇, M. Galeazzi, Ahmet Gül, Yair Levy, P Petera, R Popović, Renata Petrović, Renato Alberto Sinico, Roberto Cattaneo, Josep Font, G Depresseux, JP Cosyns, Ricard Cervera - Annals of the Rheumatic Diseases 2009 被引用: 540

  24. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

    著者: Frédéric Houssiau, David D’Cruz, Shirish Sangle, Philippe Rémy, Carlos Vasconcelos, Radmila Petrović, Christoph Fiehn, Enrique de Ramón Garrido, Inge-Magrethe Gilboe, Maria G. Tektonidou, Daniël Blockmans, Isabelle Ravelingien, Véronique Le Guern, Geneviève Depresseux, Loı̈c Guillevin, Ricard Cervera - Annals of the Rheumatic Diseases 2010 被引用: 496